Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Dova Pharmaceuticals, Inc. (DOVA) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $27.98 Metrics
OS: 28.8 M -223 % ROE
Market cap: $807 M -11671 % ROIC
Net cash: $37.6 M $1.30 per share
EV: $769 M

 
TTM Valuation
EBITDA ($72.9) M
EBIT ($73.0) M
EPS ($2.62)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues11.50.0
Cost of goods sold1.20.0
Gross profit10.40.0
            Gross margin89.8% 
Selling, general and administrative61.913.5
Research and development18.315.7
EBIT-71.1-29.2
            EBIT margin-616.0% 
Pre-tax income-72.3-30.0
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-72.3-30.0
            Net margin-626.6% 
 
Diluted EPS($2.60)($1.40)
Shares outstanding (diluted)27.821.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy